Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Mojca, Bozic Mijovski"'
1
Akademický článek
Time Course of Inflammatory and Procoagulant Markers in the Early Period After Total Hip Replacement
Autor: Peter Poredos MD, PhD, Pavel Poredos MD, PhD, Mateja K. Jezovnik MD, PhD, Ana Mavric MD, Lara Leben MD, Mojca Bozic Mijovski PhD, Paula Maia PhD, Sandra Haddad PhD, Jawed Fareed PhD
Publikováno v: Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Our study aimed to investigate the levels and time-course of systemic inflammatory and hemostasis markers in the early postoperative period in patients undergoing total hip replacement (THR). The study included 70 patients of both sexes, average age
Externí odkaz: https://doaj.org/article/6ca3a6c34f18420aa935226ee6d56e94
Zobrazit plný text záznamu
3
Biocompatibility Parameters with Standard and Increased Dose of Citrate in Hemodialysis—A Randomized Trial
Autor: Jakob Gubensek, Saša Simčič, Mojca Bozic-Mijovski, Alesa Orsag, Samo Hudoklin
Publikováno v: Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 2987, p 2987 (2021)
Volume 10
Issue 13
Background: The dose of citrate needed in regional citrate anticoagulation (RCA) to achieve optimal biocompatibility is unknown. We performed a randomized trial comparing two doses (ACTRN12613001340729). Methods: In 30 patients a single hemodialysis
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39811c007e49947083425d839691ac01
http://europepmc.org/articles/PMC8268353
Zobrazit plný text záznamu
4
Time Course of Inflammatory and Procoagulant Markers in the Early Period After Total Hip Replacement
Autor: Ana Mavric, Paula Maia, Sandra Haddad, Peter Poredos, Lara Leben, Jawed Fareed, Pavel Poredos, Mojca Bozic Mijovski, Mateja K Jezovnik
Publikováno v: Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Clinical and Applied Thrombosis/Hemostasis
Our study aimed to investigate the levels and time-course of systemic inflammatory and hemostasis markers in the early postoperative period in patients undergoing total hip replacement (THR). The study included 70 patients of both sexes, average age
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea1749124092e4dffd8d026b4b2349d5
https://doaj.org/article/6ca3a6c34f18420aa935226ee6d56e94
Zobrazit plný text záznamu
5
P1069COMPARISON OF BIOCOMPATIBILITY OF REGULAR AND INCREASED DOSE OF CITRATE IN CHRONIC HEMODIALYSIS - PRELIMINARY RESULTS OF A RANDOMIZED TRIAL
Autor: Jakob Gubensek, Mojca Bozic-Mijovski, Saša Simčič, Alesa Orsag
Publikováno v: Nephrology Dialysis Transplantation. 35
Background and Aims The dose of citrate that is needed in regional citrate anticoagulation (RCA) to achieve optimal biocompatibility of the extracorporeal circuit is not known. Insufficient biocompatibility is related with increased inflammation and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8594434b59398d6526dbbebe44ad5122
https://doi.org/10.1093/ndt/gfaa142.p1069
Zobrazit plný text záznamu
6
Increased plasma cathepsin S at the time of percutaneous transluminal angioplasty is associated with 6-months' restenosis of the femoropopliteal artery
Autor: Urša Pečar Fonović, Janja Marc, Mojca Bozic Mijovski, Janko Kos, Darko Cerne, Aleš Blinc, Vinko Boc
Publikováno v: Journal of Medical Biochemistry, Vol 37, Iss 1, Pp 54-61 (2018)
Journal of Medical Biochemistry
We tested the hypothesis that increased levels of cathepsin S and decreased levels of cystatin C in plasma at the time of percutaneous transluminal angioplasty (PTA) are associated with the occurrence of 6-months' restenosis of the femoropopliteal ar
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6384ae2e4320b16835950cd26bdf47e7
https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2018/1452-82581801054B.pdf
Zobrazit plný text záznamu
7
Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure
Autor: Borut Jug, Gorazd Kosir, Marko Novaković, Jus Ksela, Mojca Bozic Mijovski
Publikováno v: Disease Markers
Disease Markers, Vol 2019 (2019)
Background. Heart failure (HF) is characterized by unfavorable prognosis. Disease trajectory of HF, however, may vary, and risk assessment of patients remains elusive. In our study, we sought to determine the prognostic impact of endocan—a novel bi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24adf480a685d3bb7142c45a9d8898a3
http://europepmc.org/articles/PMC6476001
Zobrazit plný text záznamu
8
Platelet reactivity in comatose survivors of cardiac arrest undergoing percutaneous coronary intervention and hypothermia
Autor: Klemen Steblovnik, Marko Noc, Aleš Blinc, Enver Melkic, Igor Kranjec, Mojca Bozic-Mijovski
Publikováno v: EuroIntervention. 10:1418-1424
Aims To investigate the effects of clopidogrel and eptifibatide on platelet reactivity in patients resuscitated from cardiac arrest undergoing percutaneous coronary intervention (PCI) and hypothermia. Methods and results VerifyNow® and Multiplate®
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66cd581da727a2e09547c334dcc49fcc
https://doi.org/10.4244/eijy14m05_02
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje